ArticleWorld journal of surgical oncology2026

RGS19 drives tumor progression and immunosuppression in clear cell renal cell carcinoma by modulating CAMs and EMT.

Zhenhui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.